Seegene Launches STAgora and CURECA
Analysis based on 9 articles · First reported Apr 20, 2026 · Last updated Apr 20, 2026
The introduction of Seegene's STAgora and CURECA platforms is expected to positively impact the molecular diagnostics market by advancing real-time data analytics and automated PCR workflows. This innovation could lead to improved infectious disease management and potentially increase Seegene's market share and stock performance.
Seegene, a global molecular diagnostics company, introduced its new real-time data analytics platform, STAgora, and an enhanced model of its automated PCR workflow concept, CURECA, at ESCMID Global 2026 in Germany===Munich, Germany. The event, held from April 17-21, garnered significant interest from healthcare and laboratory professionals worldwide. STAgora is designed to aggregate and visualize PCR testing data in real time, providing insights into infectious disease trends. CURECA is a fully automated PCR system aimed at streamlining molecular testing workflows. Seegene's New Business Officer, Young-Seag Baeg, and Chief Global Sales and Marketing Officer, Daniel Shin, highlighted the platforms' potential to enhance understanding of infection patterns and improve public health. The company plans to expand pilot programs and collaborations to accelerate the adoption of these data-driven diagnostic solutions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard